Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1676
1
Centessa Pharmaceuticals plc Centessa Pharmaceuticals Reports Q3 2024 Financial Results, Net Losses, and Strategic Developments

Via official filing (AI summary) | 11 days ago | 0 comments

1677
1
Scholar Rock Holding Corp Scholar Rock Reports Significant Decline in Assets, Increased Operating Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1678
1
GLOBAL TECHNOLOGIES LTD Global Technologies, Ltd. Reports Revenue Growth, Improved Operating Efficiency, and Strategic Acquisitions in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1679
1
Viridian Therapeutics, Inc.\DE Viridian Therapeutics Reports Increased Assets, Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1680
1
Apogee Therapeutics, Inc. Apogee Therapeutics Reports Significant Financial Developments, Increased Expenses, and Net Losses

Via official filing (AI summary) | 11 days ago | 0 comments

1681
1
iTeos Therapeutics, Inc. iTeos Therapeutics Reports 178% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1682
1
ROCKWELL MEDICAL, INC. Rockwell Medical Reports 19% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1683
1
ASHFORD HOSPITALITY TRUST INC Ashford Hospitality Trust Reports Mixed Q3 2024 Results, Net Income Turnaround for Nine-Month Period

Via official filing (AI summary) | 11 days ago | 0 comments

1684
1
Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals Reports Improved Financials, Reduced Losses, and Increased Cash Reserves

Via official filing (AI summary) | 11 days ago | 0 comments

1685
1
Fathom Holdings Inc. Fathom Holdings Reports Decline in Revenue and Increased Net Losses in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1686
1
US ENERGY CORP U.S. Energy Corp. Reports 43% Revenue Decline, Operating Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1687
1
Crescent Capital BDC, Inc. Crescent Capital BDC Reports Strong Growth in Investment Income and Net Assets for Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1688
1
NET Power Inc. NET Power Reports Revenue Growth, Reduced Losses in Q3 2024, Prepares for Utility-Scale Power Plant Construction

Via official filing (AI summary) | 11 days ago | 0 comments

1689
1
Nuvalent, Inc. Nuvalent Reports Significant Asset Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1690
1
AVANT TECHNOLOGIES INC. Avant Technologies Reports Significant Financial Challenges, Net Loss, and Accumulated Deficit in Latest 10-Q Filing

Via official filing (AI summary) | 11 days ago | 0 comments

1691
1
Rigetti Computing, Inc. Rigetti Computing Reports Decline in Revenue and Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1692
1
SpringWorks Therapeutics, Inc. SpringWorks Therapeutics Reports Decrease in Cash and Cash Equivalents, Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1693
1
Atlantis Glory Inc. Atlantis Glory Inc. Reports Financial Results, Net Loss, and Cash Flow Challenges

Via official filing (AI summary) | 11 days ago | 0 comments

1694
1
Pactiv Evergreen Inc. Pactiv Evergreen Reports Decline in Financial Performance for Q3 and Nine Months of 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1695
1
TEAM INC Team, Inc. Reports Mixed Q3 Results with Revenue Growth and Improved Operating Income, but Net Loss and Equity Decline

Via official filing (AI summary) | 11 days ago | 0 comments

1696
1
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics Reports Financial Results, Focuses on Cancer Treatment Development

Via official filing (AI summary) | 11 days ago | 0 comments

1697
1
Golden Star Resource Corp. Golden Star Resource Corp. Reports Net Loss, Increased Liabilities, and Cash Deficit in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1698
1
Live Nation Entertainment, Inc. Live Nation Entertainment Reports Mixed Q3 2024 Results, Revenue Decline and Increased Debt

Via official filing (AI summary) | 11 days ago | 0 comments

1699
1
22nd Century Group, Inc. 22nd Century Group Reports Q3 2024 Financial Results with Revenue Decline, Improved Operational Efficiency, and Stronger Balance Sheet

Via official filing (AI summary) | 11 days ago | 0 comments

1700
1
Marpai, Inc. Marpai, Inc. Reports Revenue Decline, Improved Profitability, and Strategic Developments in Q3 2024 Financial Results

Via official filing (AI summary) | 11 days ago | 0 comments